Paula Soteropoulos

Paula Soteropoulos, chief executive officer of rare disease therapeutic developer Akcea Therapeutics, has worked in global drug development and commercialization for nearly 30 years, including senior roles at Genzyme and Moderna Therapeutics. She serves on the Board of Directors of uniQure N.V. and the Advisory Board of the Tufts University Chemical and Biological Engineering Department. Paula has been involved with a number of initiatives to support the development of female leadership in business, including the Healthcare Business Women’s Association and Women Unlimited. Paula has B.S. and Master’s degrees in Chemical and Biochemical Engineering from Tufts University and an executive management certificate from the Darden School of Business, University of Virginia.